{"id":518045,"date":"2021-07-27T08:03:48","date_gmt":"2021-07-27T12:03:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"},"modified":"2021-07-27T08:03:48","modified_gmt":"2021-07-27T12:03:48","slug":"orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","title":{"rendered":"Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm"},"content":{"rendered":"
\n

\n Investors with losses are encouraged to contact the firm before <\/em>
\n September 13, 2021<\/em>
\n ; click <\/em>
\n
\n here<\/em>
\n <\/a>
\n to submit trade information<\/em>\n <\/p>\n

LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm<\/u><\/a> advises investors that a class action lawsuit has been filed on behalf of Orphazyme A\/S (NASDAQ: ORPH) investors that acquired shares between April 30, 2020 and July 7, 2021. Investors have until September 13, 2021 to seek an active role in this litigation.<\/p>\n

Investors are encouraged to contact attorney Lesley F. Portnoy<\/u><\/a>,<\/u> to determine eligibility to participate in this action, by phone 310-692-8883 or email<\/u><\/a>, or click here<\/u><\/a> to join the case.<\/p>\n

It is alleged in this complaint that Orphazyme made misleading and false statements to the market. Orphazyme\u2019s arimoclomol was not an effective treatment for Inclusion Body Myositis (\u201cIBM\u201d). Additionally, Arimoclomol was not an effective treatment for Amyotrophic Lateral Sclerosis (\u201cALS\u201d). Orphazyme\u2019s new drug application (\u201cNDA\u201d) for arimoclomol for the treatment of Niemann-Pick disease type C (\u201cNPC\u201d) was incomplete and require\u2202 additional data to support its benefit-risk analysis. It was not likely that The FDA would approve the Orphazyme\u2019s NDA for arimoclomol. Orphazyme\u2019s public statements were false and materially misleading throughout the class period, based on these facts. Investors suffered damages when the market learned the truth about Orphazyme.<\/p>\n

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 13, 2021.<\/p>\n

Please visit our website<\/u><\/a> to review more information and submit your transaction information.<\/p>\n

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm\u2019s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com<\/u><\/a>
310-692-8883
www.portnoylaw.com<\/p>\n

Attorney Advertising<\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Investors with losses are encouraged to contact the firm before September 13, 2021 ; click here to submit trade information LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Orphazyme A\/S (NASDAQ: ORPH) investors that acquired shares between April 30, 2020 and July 7, 2021. Investors have until September 13, 2021 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged in this complaint that Orphazyme made misleading and false statements to the market. … <\/p>\n

Continue reading “Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-518045","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOrphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Investors with losses are encouraged to contact the firm before September 13, 2021 ; click here to submit trade information LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Orphazyme A\/S (NASDAQ: ORPH) investors that acquired shares between April 30, 2020 and July 7, 2021. Investors have until September 13, 2021 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged in this complaint that Orphazyme made misleading and false statements to the market. … Continue reading "Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-27T12:03:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Orphazyme A\\\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm\",\"datePublished\":\"2021-07-27T12:03:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"},\"wordCount\":315,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\",\"name\":\"Orphazyme A\\\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=\",\"datePublished\":\"2021-07-27T12:03:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Orphazyme A\\\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk","og_description":"Investors with losses are encouraged to contact the firm before September 13, 2021 ; click here to submit trade information LOS ANGELES, July 27, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Orphazyme A\/S (NASDAQ: ORPH) investors that acquired shares between April 30, 2020 and July 7, 2021. Investors have until September 13, 2021 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged in this complaint that Orphazyme made misleading and false statements to the market. … Continue reading \"Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-27T12:03:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm","datePublished":"2021-07-27T12:03:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"},"wordCount":315,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","name":"Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=","datePublished":"2021-07-27T12:03:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzIyMyM0MzE2MTIzIzIxOTU1Mjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orphazyme-a-s-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Orphazyme A\/S Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=518045"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518045\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=518045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=518045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=518045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}